Search results for "PREECLAMPSIA"

showing 10 items of 48 documents

Needs and preferences of women with prior severe preeclampsia regarding app-based cardiovascular health promotion

2022

Abstract Background Women with prior severe preeclampsia are at an increased risk for cardiovascular diseases later in life compared to women who had a normotensive pregnancy. The objective of this study was to assess their needs and preferences regarding app-based cardiovascular health promotion. Methods Patients (n = 35) of the Follow-Up PreEClampsia Outpatient Clinic (FUPEC), Erasmus MC, the Netherlands, participated in an anonymous online survey. The main outcomes under study were women’s needs for health behavior promotion, and their preferences with respect to intervention delivery. Descriptive statistics were used to evaluate needs, and thematic analysis was used to analyze preferenc…

Maleand promotion of well-beingnaisetcardiovascular health promotionmieltymyksettarpeetHealth BehaviorReproductive health and childbirthNursingHealth PromotionCardiovascularterveyden edistäminenPaediatrics and Reproductive MedicinepreeclampsiaPre-EclampsiaSDG 3 - Good Health and Well-beingClinical ResearchPregnancyBehavioral and Social SciencemobiilisovelluksetHumansObstetrics & Reproductive Medicineneeds and preferences assessmentNutritionPreventionObstetrics and GynecologyGeneral MedicinePrevention of disease and conditionsMobile ApplicationsStrokeGood Health and Well Beingintervention designReproductive Medicinepre-eklampsiaterveyskäyttäytyminenHypertensionPublic Health and Health Servicessydän- ja verisuonitauditinterventiohoito3.1 Primary prevention interventions to modify behaviours or promote wellbeingFemaleSugarsBMC Women's Health
researchProduct

Kidney donors and kidney transplants have abnormal aminothiol redox status, and are at increased risk of oxidative stress and reduced redox buffer ca…

2013

Abstract Objective Living kidney donors have been part of a successful kidney transplant programme in Norway for almost 50 years. Glomerular filtration rates (GFRs) have tended to remain stable at about 70% of pre-donation levels. Plasma total homocysteine (Hcy) has an inverse relationship to kidney function, and previous reports indicate elevated levels of Hcy in kidney donors. We wanted to examine the most important plasma aminothiols in kidney donors, i.e. Hcy, cysteine (Cys) and cysteinylglycine (CG) with their redox species. The aminothiol redox-system appears to be an integral part of the extracellular antioxidant defence system in the body. Design and methods Plasma concentrations of…

Malemedicine.medical_specialtyAntioxidantHomocysteinemedicine.medical_treatmentClinical BiochemistryRenal functionBuffersmedicine.disease_causeRedoxPreeclampsiachemistry.chemical_compoundRisk FactorsInternal medicineLiving DonorsmedicineExtracellularHumansCysteineSulfhydryl CompoundsHomocysteineDemographyKidneyurogenital systemDipeptidesGeneral MedicineMiddle Agedmedicine.diseaseKidney TransplantationOxidative StressEndocrinologymedicine.anatomical_structurechemistryCase-Control StudiesFemaleOxidation-ReductionOxidative stressClinical Biochemistry
researchProduct

Perceived determinants of physical activity among women with prior severe preeclampsia: a qualitative assessment.

2022

Abstract Background The objective of this study was to (1) qualitatively identify the perceived determinants of physical activity among women who have experienced severe preeclampsia, and (2) examine whether these determinants are consistent with the overarching processes outlined in the integrated behavior change (IBC) model, a novel model that describes physical activity as being a result of motivational, volitional, and automatic processes. Methods Patients (n = 35) of the Follow-Up PreEClampsia (FUPEC) Outpatient Clinic, Erasmus MC, the Netherlands, participated in an anonymous online survey. The main outcomes under study were their perceived determinants of physical activity. Responses…

Malequalitative studyphysical activityNursingliikuntaCardiovascularPaediatrics and Reproductive MedicinepreeclampsiaPre-EclampsiaClinical ResearchPregnancySurveys and QuestionnairesBehavioral and Social ScienceHumansObstetrics & Reproductive MedicinekuntoutujatExercisemotivaatioMotivationContraception/ReproductionObstetrics and GynecologySocial Supportcardiovascular healthGeneral Medicineperceived determinantsReproductive Medicinepre-eklampsiaterveyskäyttäytyminenPublic Health and Health ServicesFemalefyysinen aktiivisuusBMC women's health
researchProduct

Priekšlaicīgu dzemdību izraisītu grūtniecības komplikāciju izvērtējums.

2017

Cēlonis: Grūtniecības komplikācijas ir galvenie iemesli mātes un augļa mortality.Pregnancy komplikāciju mainās dažādās populāciju, BMI un vecuma grupā. Saskaņā ar Global Health observatoriju, kuri katru dienu 2015. gadā, aptuveni 830 sievietes nomira dēļ komplikācijas grūtniecības un bērna piedzimšanas. Tāpēc ir ļoti svarīgi, lai analizētu grūtniecības komplikācijas gan priekšlaicīgas dzemdības un normālu termiņa piegāde (vadības grupa). Mērķi: Pētījuma mērķis ir analizēt dažas grūtniecības komplikācijas un salīdzināt tos no priekšlaicīgas dzemdības un kontroles grupu, un salīdzināt tos ar vecuma grupu un ĶMI grupu. Materiāli un metodes: Pētījums modelis ietver datus, kas savākti no Rig…

Normal term deliveryPregnancy complicationPreterm deliveryPlacental ProblemsPreeclampsiaMedicīna
researchProduct

Statins and angiogenesis in non-cardiovascular diseases.

2022

Statins inhibit HMG-CoA reductase by competitively inhibiting the active site of the enzyme, thus preventing cholesterol synthesis and reducing the risk of developing cardiovascular disease. Many pleiotropic effects of statins have been demonstrated that can be either related or unrelated to their cholesterol-lowering ability. Among these effects are their proangiogenic and antiangiogenic properties that could offer new therapeutic applications. In this regard, pro- and anti-angiogenic properties of statins have been shown to be dose dependent. Statins also appear to have a variety of non-cardiovascular angiogenic effects in many diseases, some examples being ocular disease, brain disease, …

PharmacologyCholesterolNeovascularization PathologicCardiovascular DiseasesNeoplasmsDrug DiscoveryHumansHydroxymethylglutaryl-CoA Reductase InhibitorsAngiogenesis Bone disease Brain disease Cancer Cardiovascular Diabetes Ocular disease Preeclampsia Statins VascularizationDrug discovery today
researchProduct

Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsi…

2013

Background: Aim of the study was a critical assessment of the clinical validity of the prenatal determination of sFlt-1/PlGF for preeclampsia (PE), pregnancy-induced hypertension (PIH), and proteinuria. Our analysis was based on a specificity of 95 % and a sensitivity of 82 % for the prediction of preeclampsia, as described by Elecsys (Roche). Methods: In this retrospective study the ratio of the prenatal antiangiogenic factor sFlt-1 (soluble fms-like tyrosine kinase-1) to the proangiogenic factor PIGF (placental growth factor) was analyzed using the electrochemiluminescence immunoassay of Elecsys (Roche Diagnostics, Mannheim, Germany) in 173 pregnant women. Sixty-three women with PE, 34 wo…

Placental growth factorGynecologymedicine.medical_specialtyProteinuriabusiness.industryObstetrics and GynecologyIntrauterine growth restrictionmedicine.diseaseGastroenterologyArticlePreeclampsiaBlood pressurePIGFInternal medicineMaternity and Midwiferyembryonic structuresmedicineGestationmedicine.symptombusinessSoluble fms-like tyrosine kinase-1
researchProduct

Epidemiology of preeclampsia in a Sicilian Hospital

2016

Multivariate logistic regression has shown that the following variables are independent risk factors for preeclampsia: age, BMI, parity, and twin pregnancy. Moreover, preeclampsia is significantly associated with the examined clinical effects, confirming itself as a leading cause of maternal-fetal morbidity.

Preeclampsia epidemiology Sicily twin pregnancy
researchProduct

OP09.10: Hemodynamic effects of sildenafil administration in an animal model of preeclampsia

2011

Radiological and Ultrasound Technologybusiness.industrySildenafilObstetrics and GynecologyGeneral Medicinemedicine.diseasePreeclampsiachemistry.chemical_compoundAnimal modelReproductive MedicinechemistryAnesthesiaMedicineRadiology Nuclear Medicine and imagingbusinessAdministration (government)Hemodynamic effectsUltrasound in Obstetrics & Gynecology
researchProduct

Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption

2003

Placental abruption is an unpredictable severe complication in pregnancy. In order to investigate the possibility that the activation of the fetal nonadaptive immune system may be involved in the pathogenesis of this disease, IL-6 release from cord blood monocytes was examined by intracellular cytokine staining and flow cytometric analysis. Our results demonstrate that preterm placental abruption (n = 15) in contrast to uncontrollable preterm labor (n = 33) is associated with significantly (P < 0.001) increased release of IL-6 from the fetal monocytes. The same holds true for rhesus disease (n = 9, P < 0.001) that is characterized by a maternal production of antibodies against the rhesus-D …

Time FactorsImmunologyAntibodiesMonocytesPreeclampsiaPathogenesisFetusObstetric Labor PrematureImmune systemHLA AntigensPregnancyHumansImmunology and AllergyMedicineAbruptio PlacentaeFetusPregnancybiologyPlacental abruptionbusiness.industryImmunityFetal Bloodmedicine.diseaseFetal circulationImmunologybiology.proteinFemaleAntibodybusinessClinical Immunology
researchProduct

Use of Antihypertensive Drugs During Preeclampsia

2018

Treatment of pregnancy-related hypertensive disorders, such as preeclampsia (PE), remain a challenging problem in obstetrics. Typically, aggressive antihypertensive drug treatment options are avoided to prevent pharmacological-induced hypotension. Another major concern of administering antihypertensive drugs during pregnancy is possible adverse fetal outcome. In addition, management of hypertension during pregnancy in chronic hypertensive patients or in patients with prior kidney problems are carefully considered. Recent studies suggest that PE patients are at increased cardiovascular risk postpartum. Therefore, these patients need to be monitored postpartum for the subsequent development o…

lcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyhypertensionmedicine.drug_classMini ReviewCardiovascular MedicinePreeclampsiapreeclampsia03 medical and health sciences0302 clinical medicineMedicineIn patient030212 general & internal medicineAntihypertensive drugIntensive care medicinePregnancy030219 obstetrics & reproductive medicinebusiness.industrycardiovascularTreatment optionsmedicine.diseaseReview articlelcsh:RC666-701antihypertensive drugsFetal outcomepregnancyCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct